Institutional investors hold a majority ownership of AGN through the 91.59% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2014, these large investors purchased a net $3.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PENTWATER CAPITAL MANAGEMENT LP Bought 1.9 Million shares of Allergan
FARALLON CAPITAL MANAGEMENT LLC Bought 1.4 Million shares of Allergan
ARROWGRASS CAPITAL PARTNERS (US)... Bought 1.3 Million shares of Allergan